TJL UK
Leading pharmaceutical company headquartered in the UK, specializing in innovative treatments.
TJL DUBAI
Branch of TJL UK, focused on pharmaceutical development and innovation in Dubai.
TJL CHINA
Branch of TJL UK, focused on pharmaceutical development and innovation in Dubai.
TJL AFGHANISTAN
Branch of TJL UK, focused on pharmaceutical development and innovation in Afghanistan.
OUR CORE VALUES
We work in environment that bring values
TJL GROUP OF COMPANY is a healthcare company dedicated to manufacturing and providing the best quality intravenous infusion solutions. Our products are prepared with precision and accuracy, ensuring consistent and predictable treatment for patients around the world.
At TJL Pharmaceutical, we believe that investing in research and development is crucial to our mission of improving healthcare on a global scale. Our R&D department is staffed with experienced scientists, pharmacists, and other experts who are dedicated to discovering and developing new medicines and treatments to address some of the most pressing health challenges worldwide
FEATURES
TJL Pharma’s Commitment to Innovative Solutions and Superior Quality
I am honored to serve as the Director and CEO of TJL GROUP OF COMPANIES, one of the leading pharmaceutical companies globally. Our company is committed to providing high-quality, affordable, and accessible medicines to people worldwide.
TJL GROUP OF COMPANIES is dedicated to manufacturing and providing the best quality intravenous infusion solutions, prepared with precision and accuracy to ensure consistent and predictable treatment for patients around the world.
Our mission is to contribute to the healthcare system by providing low-cost, high-quality medicines, bringing better health and a brighter future to patients by translating science into life-changing treatments. We are also focused on training local expertise, creating jobs, and contributing to industrial and economic development globally. TJL GROUP OF COMPANIES was founded by Tawab Jan in 2022.
MR.TAWAB JAN
FOUNDER, CEO of TJL GROUP OF COMPANY’S
Worldwide Experience
We Always Try To Understand
Users Expectation
At TJL Pharma, we put our customers at the heart of everything we do. We are committed to understanding the unique needs and expectations of our users, ensuring that we deliver solutions that truly make a difference. With a focus on quality and innovation, we constantly strive to exceed expectations and build trust through reliable, user-focused services.
OUR PURPOSE
We bring science and innovation together
Our R&D department has experienced staff scientists, chemists, pharmacists, and other experts who are dedicated to discovering and developing new medicines and treatments to address some of the most pressing health challenges facing our region.
Our R&D team works tirelessly to identify and evaluate potential new drug candidates and to advance those with the most promising results through the rigorous testing and approval processes required to bring new treatments to market. We also invest in ongoing research into the safety and efficacy of our existing products, constantly seeking ways to improve and enhance the benefits they provide to our patients.
Clinical Development
Clinical Development involves designing, conducting, and analyzing trials to test new drugs or treatments for safety and efficacy.
Biotech
Biotech uses biological processes to develop products and technologies, including drugs, diagnostics, and therapies, often through genetic and cellular manipulation.
Regulatory & Access
Regulatory & Access focuses on obtaining approvals and ensuring market access for new treatments, navigating compliance, and addressing health policy.
Functional Service
Functional Service provides specialized expertise and support in areas like clinical trials, data management, or regulatory affairs, enhancing operational efficiency for clients.
OUR PURPOSE
Better medicines improve healthcare is our commitment.
Procedure quality medicines ensure “current good manufacturing practice(cGMP)” to serve humanity in the best possible manner as we believe that “health care and wellbeing of patient” is our first and foremost responsibility and priority.
To discover, developed, and trade pharmaceutical products to prevent, diagnose, alleviate, and cure.
Our mission is to add value to our partners and customers by continuously improving our product quality. We aim to contribute to the healthcare system of Afghanistan, to ease the availability of high- quality medicines, and to bring better health and a brighter future in terms of life-saving medicines to the general public.
TJL GROUP OF COMPANY
Products List
| S.no | Generic | Strenght | Pack size | Trademark | Dosage form | Product Area | Remarks | ||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ciprofloxacin | 200 mg | 100ml | LifeSol-Cipro | LDPE Infusion | General medicine | Ready | ||
| 2 | Ciprofloxacin | 200 mg | 100ml | LifeSol-Cipro | P.P Infusion | General medicine | Ready | ||
| 3 | Ciprofloxacin | 200 mg | 100ml | LifeSol-Cipro | Glass Infusion | General medicine | Ready | ||
| 4 | Dextrose | 5% | 1000ml | LifeSol-G5 | LDPE Infusion | General medicine | Ready | ||
| 5 | Dextrose | 5% | 500ml | LifeSol -G5 | LDPE Infusion | General medicine | Ready | ||
| 6 | Dextrose | 5% | 100ml | LifeSol- G5 | LDPE Infusion | General medicine | Ready | ||
| 7 | Dextrose | 10% | 1000ml | LifeSol -G10 | LDPE Infusion | General medicine | Ready | ||
| 8 | Dextrose | 10% | 500ml | LifeSol-G 10 | LDPE Infusion | General medicine | Ready | ||
| 9 | Dextrose + Sodium Chloride | 5% + 0.9% | 1000ml | LifeSol- DS | LDPE Infusion | General medicine | Ready | ||
| 10 | Dextrose + Sodium Chloride | 5% + 0.9% | 500ml | LifeSol -DS | LDPE Infusion | General medicine | Ready |
